Benzinga's Top Downgrades By: Benzinga via Benzinga March 06, 2015 at 09:07 AM EST Analysts at Nomura downgraded Pharmacyclics Inc. (NASDAQ: PCYC) from Buy to Neutral. The price target for Pharmacyclics has been raised ... Read More >> Related Stocks: State Street Corp